Study: 397 Children diagnosed with heart
inflammation after receiving Pfizer’s COVID-19 vaccine
Tuesday, August 03, 2021 by: Nolan Barton
Tags: adverse reaction, badhealth, badmedicine, badscience, Big Pharma, chest pain, covid-19, COVID-19 vaccine, heart inflammation, intracranial hemorrhage, mRNA technology, myocarditis, pharmaceutical fraud, pulmonary embolism, research, vaccine injury, VAERS
7,960VIEWS
(Natural News) A study published by the Centers for Disease Control and Prevention (CDC) on July 30 found that 397 children between the ages of 12 and 17 were diagnosed with heart inflammation called myocarditis after receiving the Pfizer-BioNTech coronavirus (COVID-19) vaccine.
The condition occurred mostly in young boys. Heart inflammation was not identified as an adverse reaction during the
safety trials for the vaccine, but the CDC announced in June that the Food
and Drug Administration (FDA) would add a warning to
the Pfizer and Moderna coronavirus (COVID-19)
vaccines about a possible link to cases of myocarditis in teenagers and
young adults.
Myocarditis is a condition that involves inflammation of the
heart muscle. Symptoms can include fever and fatigue, as well as shortness of
breath and a very specific type of chest pain. Patients tend to say their chest
hurts more when they lean forward.
The Advisory Committee
on Immunization Practices (ACIP), CDC’s vaccine advisory group, met in June
to discuss instances of myocarditis in people aged 30 and younger who have
received an mRNA COVID-19 vaccine. (Related: Exclusive: Athlete who
recovered from COVID facing ‘very different future’ after second dose of Pfizer
vaccine triggers myocarditis.)
Pfizer and Moderna use mRNA
technology in their COVID-19 vaccines, while Johnson & Johnson uses the
more traditional virus-based technology.
The COVID-19 Vaccine
Safety Technical (VaST) Work Group, which is part of ACIP, assessed the
reported cases and noted that the risk of myocarditis following vaccination
with the mRNA-based vaccines in adolescents and young adults is notably higher
after the second dose, particularly in males.
According to VaST, the data
suggests a likely association of
myocarditis with mRNA vaccination in adolescents and young adults.
New study is based on reports of adverse reactions among children
The CDC conducted the new
study by reviewing reports of adverse reactions to
the Vaccine Adverse Event Reporting System (VAERS) between Dec.
14, 2020 and July 16, 2021.
VAERS received a total
of 9,246 reports of adverse reactions among children during that period,
90.7 percent of which were made up of “non-serious adverse events.” The 397
reports of heart inflammation made up 4.3 percent of the total.
Fourteen children died
after receiving the Pfizer vaccine, according to the study. The cause of death
was not available for six of the cases. Of the eight other children, two died
of intracranial hemorrhage, two died of pulmonary embolism, two
committed suicide, one died of heart failure and one died of a blood condition.
None of the reported deaths had been caused by heart inflammation.
“Impressions regarding
cause of death did not indicate a pattern suggestive of a causal relationship
with vaccination. However, cause of death for some decedents is pending receipt
of additional information,” wrote Anne Hause, the CDC’s corresponding author.
Hause noted that the study
is subject to several limitations, including the fact that “VAERS is a passive
surveillance system and is subject to underreporting and reporting biases.”
Though the system is
considered passive overall, doctors are required to report all serious events
following vaccinations. The study also wasn’t designed to capture all cases of
heart inflammation and only counted the reports which used the term
“myocarditis.”
The FDA issued an emergency
use authorization for the Pfizer vaccine for children 16 years and older on
Dec. 11, 2020 and expanded the authorization to children 12 and over
on May 10, 2021. (Related: More child guinea pigs
needed: FDA asks for more children to take part in experimental trials of
deadly coronavirus vaccines.)
CDC’s vaccine advisory group still wants children to take the risk
After reports of heart
inflammation began to emerge in June, the ACIP concluded that the risks of
high inflammation didn’t outweigh the benefits of Pfizer’s COVID-19 vaccine and
decided to continue recommending it to children aged 12 and older.
The higher-than-expected
rate of myocarditis cases among Americans below 30 is consistent with the data
from Israel.
Israel’s Ministry
of Health identified over 200
cases of myocarditis in men between 16 and 30 years old, a vast
majority of those happening at the younger end of that range. That equates to a
risk of between 1 in 3,000 and 1 in 6,000 of suffering from heart
inflammation.
Pfizer previously said it
had not observed a higher rate of heart inflammation than would normally be
expected in the general population. Moderna also said that it could not
identify a causal association with the heart inflammation cases
and its vaccine.
Follow Immunization.news for more news and information related to coronavirus vaccines.
Sources
include:
